Title: New onset Refractory status epilepticus: a case report

Authors: Dr Ganesan Vivek, Prof. Dr Lailu Mathews, Prof. Dr K. Subramaniyan, Dr Sanjeev Kumar, Dr Maria Francis Roch.Y

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.60

Abstract

Refractory status epilepticus is a neurological condition that follows a febrile illness. One variant of RSE is FIRES. Sequelae of FIRES include neuropsychological impairments occurring without latency. Clinical knowledge about FIRES is very scarce as it is rare manifestation. Patients usually present with prolonged period of refractive epileptic events which do not respond to first- and second-line anticonvulsant drugs. Though Few previously observed cases reported its association with autoantibodies, but no perticular antibody was found to be specific for the disease till now. Treatment of FIRES is difficult and it depends on the responsiveness of the patient to antiepileptic drugs along with anesthetics steroids and other supportive drugs. Mortality rate is high and few cases have reported relapses. early management is necessary in order to achieve control of the critically ill patient, control long term seizures and improve the quality of life of the patient.

Keywords: Immunity, Refractory status epilepticus, Febrile infection-related epilepsy syndrome (FIRES), Epilepsy, Seizure, Fever, Antiepileptics, Infection 

Key Messages

FIRES is a serious neurological manifestation, that require early management of refractive seizures. Till now no specific diagnostic and management protocols were  formalized. Aggressive treatment is required in the intensive care units to reduce the morbidity and mortality of the patient.

References

  1. Gaspard N, Hirsch LJ, Sculier C, Loddenkemper T, van Baalen A, Lancrenon J, et al. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia. 2018;59(4):745-52.
  2. Verma R, Raut TP, Giri P, Praharaj HN. New onset refractory status epilepticus (NORSE) as the heralding manifestation of herpes simplex encephalitis. BMJ Case Reports. 2013;2013:bcr2013009466.
  3. Nicolas Gaspard LJH. New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) national organisation for rare disorders. [Available from: https://rarediseases.org/rare-diseases/new-onset-refractory-status-epilepticus-norse/.
  4. Wilder-Smith EP, Lim EC, Teoh HL, Sharma VK, Tan JJ, Chan BP, et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore. 2005;34(7):417-20.
  5. van Baalen A, Vezzani A, Hausler M, Kluger G. Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis. Neuropediatrics. 2017;48(1):5-18.
  6. Kramer U, Shorer Z, Ben-Zeev B, Lerman-Sagie T, Goldberg-Stern H, Lahat E. Severe refractory status epilepticus owing to presumed encephalitis. J Child Neurol. 2005;20(3):184-7.
  7. Nabbout R, Mazzuca M, Hubert P, Peudennier S, Allaire C, Flurin V, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia. 2010;51(10):2033-7.

Corresponding Author

Dr Ganesan Vivek

MBBS, MD, PG Student, Department of Anaesthesiology and Critical Care, Chettinad Medical College & Research Institute

Mobile no:  7397361658, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.